Arvinas (ARVN) EBIT Margin Growth (1y) (2018 - 2026)
Arvinas (ARVN) EBIT Margin Growth (1y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Arvinas |
492.16 Mn |
-122.74 Mn |
- |
-44,679.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-44,679.00 |
| Dec 31, 2025 |
-68,695.00 |
| Sep 30, 2025 |
-4,565.00 |
| Jun 30, 2025 |
-25,580.00 |
| Mar 31, 2025 |
36,707.00 |
| Dec 31, 2024 |
-48,184.00 |
| Sep 30, 2024 |
15,470.00 |
| Jun 30, 2024 |
7,348.00 |
| Mar 31, 2024 |
-5,940.00 |
| Dec 31, 2023 |
58,353.00 |
| Sep 30, 2023 |
-1,991.00 |
| Jun 30, 2023 |
5,779.00 |
| Mar 31, 2023 |
-5,211.00 |
| Dec 31, 2022 |
-5,693.00 |
| Sep 30, 2022 |
31,493.00 |
| Jun 30, 2022 |
74,896.00 |
| Mar 31, 2022 |
54,045.00 |
| Dec 31, 2021 |
47,689.00 |
| Sep 30, 2021 |
-9,069.00 |
| Jun 30, 2021 |
-48,286.00 |
